Rare diseases
Investigational molecules
Locations
A study to evaluate the effectiveness and safety of duvakitug in patients with moderate to severe Crohn's disease
ItalyA study to evaluate the efficacy and safety of duvakitug in patients with moderate to severe Crohn's disease
ItalyPhase III Randomized Study of Rilvegostomig vs. Pembrolizumab with Platinum-based Chemotherapy in PD-L1 Expressing Metastatic Squamous NSCLC
ItalyA Study Comparing Empasiprubart Versus Intravenous Immunoglobulin in Adults With Chronic Inflammatory Demyelinating Polyneuropathy
ItalyA study to evaluate the safety of dazodalibep in patients with Sjögren's Syndrome over a long period of time
ItalyStudy of BNT327 with etoposide and carboplatin compared to atezolizumab with etoposide and carboplatin for patients with untreated extensive-stage small-cell lung cancer
ItalyA study testing XmAb942 compared to placebo in adults with moderate-to-severe active ulcerative colitis
ItalyA study testing molnupiravir in adults with COVID-19 who are not hospitalized and are at high risk for serious illness
ItalyLong-term safety study of deucravacitinib compared to ustekinumab in adults with moderate to severe plaque psoriasis
ItalyA Study of Long-acting Antibodies SPY001-001 and SPY002 Alone and Combined for Adults with Moderate to Severe Ulcerative Colitis
ItalyA study of navenibart for long-term safety in patients with hereditary angioedema
ItalyA study comparing XL092 versus everolimus in patients with previously treated advanced or metastatic neuroendocrine tumors
ItalyTell us about your condition – we search every trial in Europe and connect you with the right site.
